Literature DB >> 27194492

Predicting Occurrence of Spine Surgery Complications Using "Big Data" Modeling of an Administrative Claims Database.

John K Ratliff1, Ray Balise2, Anand Veeravagu2, Tyler S Cole2, Ivan Cheng2, Richard A Olshen2, Lu Tian2.   

Abstract

BACKGROUND: Postoperative metrics are increasingly important in determining standards of quality for physicians and hospitals. Although complications following spinal surgery have been described, procedural and patient variables have yet to be incorporated into a predictive model of adverse-event occurrence. We sought to develop a predictive model of complication occurrence after spine surgery.
METHODS: We used longitudinal prospective data from a national claims database and developed a predictive model incorporating complication type and frequency of occurrence following spine surgery procedures. We structured our model to assess the impact of features such as preoperative diagnosis, patient comorbidities, location in the spine, anterior versus posterior approach, whether fusion had been performed, whether instrumentation had been used, number of levels, and use of bone morphogenetic protein (BMP). We assessed a variety of adverse events. Prediction models were built using logistic regression with additive main effects and logistic regression with main effects as well as all 2 and 3-factor interactions. Least absolute shrinkage and selection operator (LASSO) regularization was used to select features. Competing approaches included boosted additive trees and the classification and regression trees (CART) algorithm. The final prediction performance was evaluated by estimating the area under a receiver operating characteristic curve (AUC) as predictions were applied to independent validation data and compared with the Charlson comorbidity score.
RESULTS: The model was developed from 279,135 records of patients with a minimum duration of follow-up of 30 days. Preliminary assessment showed an adverse-event rate of 13.95%, well within norms reported in the literature. We used the first 80% of the records for training (to predict adverse events) and the remaining 20% of the records for validation. There was remarkable similarity among methods, with an AUC of 0.70 for predicting the occurrence of adverse events. The AUC using the Charlson comorbidity score was 0.61. The described model was more accurate than Charlson scoring (p < 0.01).
CONCLUSIONS: We present a modeling effort based on administrative claims data that predicts the occurrence of complications after spine surgery. CLINICAL RELEVANCE: We believe that the development of a predictive modeling tool illustrating the risk of complication occurrence after spine surgery will aid in patient counseling and improve the accuracy of risk modeling strategies.
Copyright © 2016 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 27194492     DOI: 10.2106/JBJS.15.00301

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  16 in total

1.  Development and internal validation of predictive models to assess risk of post-acute care facility discharge in adults undergoing multi-level instrumented fusions for lumbar degenerative pathology and spinal deformity.

Authors:  Ayush Arora; Joshua Demb; Daniel D Cummins; Vedat Deviren; Aaron J Clark; Christopher P Ames; Alekos A Theologis
Journal:  Spine Deform       Date:  2022-09-20

2.  Prediction Models for 30-Day Mortality and Complications After Total Knee and Hip Arthroplasties for Veteran Health Administration Patients With Osteoarthritis.

Authors:  Alex Hs Harris; Alfred C Kuo; Thomas Bowe; Shalini Gupta; David Nordin; Nicholas J Giori
Journal:  J Arthroplasty       Date:  2017-12-13       Impact factor: 4.757

3.  Is There an Association Between Prophylactic Femur Stabilization and Survival in Patients with Metastatic Bone Disease?

Authors:  Travis C Philipp; Jacob D Mikula; Yee-Cheen Doung; Kenneth R Gundle
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

4.  Administrative Data Are Unreliable for Ranking Hospital Performance Based on Serious Complications After Spine Fusion.

Authors:  Jacob K Greenberg; Margaret A Olsen; John Poe; Christopher F Dibble; Ken Yamaguchi; Michael P Kelly; Bruce L Hall; Wilson Z Ray
Journal:  Spine (Phila Pa 1976)       Date:  2021-09-01       Impact factor: 3.241

5.  Neurologic Disease Is a Risk Factor for Revision After Lumbar Spine Fusion.

Authors:  Steven D Glassman; Leah Y Carreon; John R Dimar; Jeffrey L Gum; Mladen Djurasovic
Journal:  Global Spine J       Date:  2019-02-06

6.  Prediction Models in Degenerative Spine Surgery: A Systematic Review.

Authors:  Daniel Lubelski; Andrew Hersh; Tej D Azad; Jeff Ehresman; Zachary Pennington; Kurt Lehner; Daniel M Sciubba
Journal:  Global Spine J       Date:  2021-04

7.  Computer-assisted surgical navigation is associated with an increased risk of neurological complications: a review of 67,264 posterolateral lumbar fusion cases.

Authors:  Remi M Ajiboye; Jayme C B Koltsov; Brian Karamian; Steven Swinford; Blake K Montgomery; Alexander Arzeno; Chason Ziino; Ivan Cheng
Journal:  J Spine Surg       Date:  2019-12

8.  Comparison of cost and complication rates for profiling hospital performance in lumbar fusion for spondylolisthesis.

Authors:  Jacob K Greenberg; Margaret A Olsen; Christopher F Dibble; Justin K Zhang; Brenton H Pennicooke; Ken Yamaguchi; Michael P Kelly; Bruce L Hall; Wilson Z Ray
Journal:  Spine J       Date:  2021-06-20       Impact factor: 4.166

9.  Are Randomized Controlled Trials the (G)old Standard? From Clinical Intelligence to Prescriptive Analytics.

Authors:  Sven Van Poucke; Michiel Thomeer; John Heath; Milan Vukicevic
Journal:  J Med Internet Res       Date:  2016-07-06       Impact factor: 5.428

10.  Nationwide prediction of type 2 diabetes comorbidities.

Authors:  Piotr Dworzynski; Martin Aasbrenn; Klaus Rostgaard; Mads Melbye; Thomas Alexander Gerds; Henrik Hjalgrim; Tune H Pers
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.